News Article | November 16, 2016
ICW Group Insurance Companies, a group of property and casualty carriers, proudly announced today that the National Health Care Anti-Fraud Association (NHCAA), a national taskforce focused on fighting health care fraud, awarded ICW Group’s Special Investigation Unit (SIU) “Investigation of the Year” for its significant contribution to the successful resolution of Operation Back Lash—one of the largest workers’ compensation health care bribery schemes ever uncovered in San Diego County. Michael Bender, assistant vice president and head of ICW Group’s SIU team accepted the award on behalf of the company at NHCCA’s 2016 Annual Training Conference in Atlanta. “We’re proud to have partnered with the FBI, California Department of Insurance, San Diego County District Attorney’s Office, and other law enforcement agencies and carriers to detect, deter and defeat one of the largest fraud crime rings in the industry,” said Bender. The Operation Back Lash investigation defeated a bribery scheme involving doctors, chiropractors, medical providers, lawyers and their associates that bought and sold patients like cattle—supplanting patient care with greed. The criminals had defrauded insurance carriers and their customers for more than $50 million. The investigation rolled out in two phases. Phase one concluded in November 2015—it resulted in eight medical professionals and associates being charged in a $25 million bribery scheme. The second wave was in January 2016 with an additional 13 indictments. Using its propriety antifraud analytics tool—Analysis Investigation Module (A.I.M.™)—ICW Group provided law enforcement agencies with actionable insights that helped authorities bust the crime ring. “A consortium of our top talent developed this first-of-its-kind platform to move at the speed of fraud,” said Bender. “We plan to continue sharing our data and intel with law enforcement, and look forward to accelerating our commitment to protecting our customers from fraud rings.” About ICW Group Based in San Diego, ICW Group Insurance Companies is the largest privately held group of insurance companies domiciled in California. Quoting more than $3 billion annually, ICW Group represents a group of Property, Auto and Workers’ Compensation insurance carriers, including Insurance Company of the West and Explorer Insurance Company. ICW Group is recognized nationally as an industry leader in helping policyholders achieve fewer and less costly claims, and is committed to meeting the needs of its policyholders and elevating the trusted agents and brokers who advise them. More information is available at http://www.icwgroup.com, http://www.twitter.com/ICWGroup, http://www.linkedin.com/companies/icw-group and http://www.facebook.com/ICWGroup.
Baudet J.-S.,Hospital San Juan Of Dios Tenerife |
Aguirre-Jaime A.,Investigation Unit
European Journal of Gastroenterology and Hepatology | Year: 2012
Aim: The aim of this research was to assess how the use of sedation during colonoscopy influences patient anxiety, fear, satisfaction, and acceptance of repeat examinations. MATERIALS AND Methods: A prospective case-control study quantifying the anxiety and fears of patients appointed for colonoscopy, comparing patients who had undergone previous colonoscopies with sedation (cases) with patients who had undergone previous colonoscopies without sedation and patients who had never had a colonoscopy before (controls). Following the examination, patients answered a satisfaction survey and were asked whether they would be willing to undergo future colonoscopies. Results: The study included 2016 patients (average age 50.05±14.44 years; 47% men). Of these, 1270 patients (63%) were undergoing colonoscopy for the first time and 746 (37%) had undergone the procedure before; in the latter group, 313 patients (42%) had been provided sedation, whereas 433 (58%) had not. Patients who had been sedated for prior colonoscopies assigned significantly lower scores than patients who had undergone previous colonoscopies without sedation and those undergoing the procedure for the first time both in the anxiety survey (3.3±2.5 vs. 7.5±2.8 vs. 10.3±3.5; P<0.01) and in the fears survey (7.1±3.0 vs. 14±2.8 vs. 20.3±4.5; P<0.01). Satisfaction survey scores were significantly higher among sedated patients than among nonsedated patients (22.8±2.7 vs. 18.6±2.3). The percentage of sedated patients who would be willing to undergo colonoscopy again was significantly higher than that of nonsedated patients (70 vs. 25%; P<0.001). Conclusion: Sedation reduces the anxiety and fear of undergoing a repeat colonoscopy and improves both patient satisfaction and the acceptability of future procedures. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Ruiz-Rebollo M.L.,Investigation Unit |
Sanchez-Antolin G.,Investigation Unit |
Garcia-Pajares F.,Investigation Unit |
Fernandez-Orcajo P.,Investigation Unit |
And 4 more authors.
Transplantation Proceedings | Year: 2010
Longer survival for orthotopic liver transplantation (OLT) patients over the last decade has focused emphasis on the metabolic complications that contribute to patient morbidity and mortality. The aim of our study was to analyze the prevalence of the metabolic syndrome (MS) and other risk factors after OLT among our patients at 1 year follow-up. From 2001 to 2008, we performed OLT in 210 patients with 62 exclusions leaving 148 patients for the study. We recorded age, gender, liver disease, smoking status, pre- and post-OLT body mass index, pre- and post-OLT arterial blood pressure, pre- and post-OLT fasting blood glucose, pre- and post-OLT high-density lipoproteins and triglycerides, family history of diabetes, hepatitis B and C virus status, immunosuppressive therapy, and corticosteroid bolus for rejection episodes. The MS was defined according to modified ATP III criteria. At month 12 after OLT, 29/148 patients (19.6%) developed the MS. The associated factors were obesity and hyperlipidemia pre-OLT, familial and personal history of diabetes as well as alcoholic cirrhosis. By multivariate analysis, pre-OLT body mass index (odds ratio, 3.7 [1.3-10.5]) and pre-OLT diabetes (odds ratio, 2.9 [1.1-7.9]) were independent risk factors. © 2010 Elsevier Inc. All rights reserved.